1. Home
  2. Live Updates
  3. Eningococcal disease

Live Breaking News & Updates on Eningococcal disease

Stay informed with the latest breaking news from Eningococcal disease on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Eningococcal disease and stay connected to the pulse of your community

Boston doctor explains health officials' concern about certain bacteria

The CDC says cases of one type of invasive disease are nearly 77 percent higher than they were at this time last year.

5-on-your-health , Frican-americans , Lack-people , Oston-news , Assachusetts , Eisseria-meningitidis , Loodstream-infections , Ass-general-doctor-explains-why-health-officials-are-concerned-about-certain-bacteria , Eningitis-cases , Eningococcal-disease , Eople-ages-30-60

New Malaria Vaccine Proven Effective in Phase 3 Study

The vaccine protected children under the age of 1.5 years against infection with an efficacy of 68%-75%.

United-kingdom , Tanzania , Burkina-faso , Berlin , Germany , Mali , Kenya , Amsterdam , Noord-holland , Netherlands , Mehreen-datoo , Beate-kampmann

Novel Myasthenia Gravis Therapies Bring Opportunities

New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.

Japan , Phoenix , Arizona , United-states , James-howard , Pushpa-narayanaswami , Drug-administration , American-association-for-neuromuscular-electrodiagnostic-medicine , American-association , Electrodiagnostic-medicine , Myasthenia-gravis , Muscular-atrophy

Sustained Benefit for Newly Approved Myasthenia Gravis Drug

Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.

Virginia , United-states , Richmond , Phoenix , Arizona , Miriam-freimer , Department-of-neurology , Drug-administration , Ohio-state-university , American-association-of-neuromuscular-electrodiagnostic-medicine , Division-of-neuromuscular-disorders , Mg-foundation-of-america

'Tripledemic': Your Questions Answered

A second flu vaccine? Immunization and the immunocompromised? The CDC's Dr Manisha Patel answers questions from the recent Medscape Masters panel on this year's respiratory virus season.

United-states , America , Eric-topol , Manisha-patel , Pneumorecs-vaxadvisor , Advisory-committee-on-immunization-practices , Pfizer , Infectious-diseases-society-of-america , Advisory-committee , Immunization-practices , Infectious-diseases-society , Coronavirus

New Meningococcal Vaccine Wins FDA Approval

The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.

Virginia , United-states , New-york , Annaliesa-anderson , Jana-shaw , Advisory-committee-on-immunization-practices , Us-centers-for-disease , Pfizer , Drug-administration , Five-common , Upstate-golisano-children , Disease-control

Pfizer Meningococcal Vaccine Nabs FDA Nod, Offering More Convenient Dosing

The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses all of them in a single vaccine, making dosing easier for patients.

United-kingdom , British , Annaliesa-anderson , Prevention-advisory-committee-on-immunization-practices , Pfizer , Centers-for-disease , Disease-control , Advisory-committee , Weight-loss , Besity , Verweight , Diabetes

Three Tuberculosis Vaccines Reach Final Stage of Development

Around 15 vaccine candidates are being developed in the battle against tuberculosis to compensate for the poor efficacy of the Bacillus Calmette-Guérin vaccine.

Saint-antoine , Aquitaine , France , Mayotte , Paris , France-general- , Spain , Guyana , Germany , Spanish , German , French

El Niño Poses a Major Health Risk

The weather phenomenon, which is accentuated by climate change, can promote malnutrition, cholera, typhoid fever, and even gender-based violence.

Pacific-ocean , World-health-organization , Tropical-infection , Ropical-disease , Malaria , Typhoid-fever , Nteric-fever , Global-warming , Dengue , Engue-fever , Chikungunya-virus , Hikungunya-fever

How did COVID-19 pandemic restrictions impact invasive meningococcal disease trends?

The impact of COVID-19 pandemic restrictions on the incidence and strain distribution of meningococcus.

United-kingdom , Viorel-kurnosov-shutterstock , World-health-organization , National-health-service , Office-for-national-statistics , United-kingdom-health-security-agency , Image-credit , Health-security-agency , Meningococcal-reference-unit , Polymerase-chain-reaction , Public-multi-locus-sequence-typing , National-statistics